Clinical Trials Logo

Clinical Trial Summary

A randomized, double-blinded, placebo-controlled trial of uninterrupted transdermal nitrate therapy in 140 peri- or postmenopausal women who have frequent hot flashes. Women will be randomly assigned to uninterrupted use of transdermal nitrate therapy (participant directed dose-escalation of 0.2 to 0.6 mg/hr) or identical-appearing placebo patches for 12 weeks.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02714205
Study type Interventional
Source University of California, San Francisco
Contact
Status Completed
Phase Phase 2
Start date April 24, 2017
Completion date April 5, 2022